INS and diabetes mellitus: According to a retrospective study of 204 patients with PPGLs and secondary DM, 40% of patients are controlled on diet, 27% of patients receive metformin as monotherapy or in combination with other oral anti-diabetic medications (sulfonylureas or dipeptidyl peptidase 4 inhibitors) and 33% of patients are insulin-treated [7].